Back to blog

The neglected Switzerland? Investing in the assets of the Alpine "vault" pays off in the long term

Switzerland has a reputation around the world as a safe haven where investors withdraw their liquidity in turbulent times to protect them from the choppy waters of the financial markets. A number of assets and stock titles offer interesting opportunities even in calm times and over the long term. Let's take a look at how you can invest in assets that are "at home" in Switzerland.

The neglected Switzerland?  Investing in the assets of the Alpine "vault" pays off in the long term

Curious thing about the franc

 

The Swiss franc represents a currency that is in the focus of investors' interest at almost any time. It wasn't long ago that the Swiss currency grew so strong that it was already threatening the competitiveness of the Swiss economy. The Swiss National Bank even began intervening against the domestic currency in 2015, a regime that it continued to apply until the end of September 2022.

 

The franc then began to strengthen again, both against the euro and the Czech crown. So far this year, this trend has stopped or even slightly reversed. The Swiss franc has embarked on a trajectory of gradual depreciation that has been unprecedented for years.

 

This is despite the fact that the Swiss National Bank's main interest rate was raised to 1.75 per cent last June and has been at this level ever since. The reason for the franc's depreciation may thus be the slight decline in interest rates on Swiss government bonds. This has fallen from around 1.5 per cent last March to 0.83 per cent today.

 

In addition, there are increasing signs that the Swiss National Bank will move to lower its base rate in the near future, as it is satisfied with the way inflation is developing there. This would mean that the Swiss franc will continue to be under selling pressure, which is of course good news for investors looking for interesting opportunities in the Swiss stock market. Moreover, the Swiss franc has performed differently in recent years than has been the norm in the major global equity markets, i.e. its performance has been significantly lower.

 

All of these factors suggest that a relatively favourable constellation for investment in Swiss assets has emerged.

 

Investing in index

 

So how to go about it? There are several options. A safer strategy is to invest in an equity index. This is not a Swiss specific strategy, but a fairly common strategy for individual investors who invest at regular intervals in an ETF that replicates an equity index in the composition of its equity portfolio. So if you are interested in Swiss equities, then choose an ETF that focuses on the main Swiss stock market index. This is the SMI (Swiss Market Index), which includes the 20 most attractive Swiss stock market titles.

 

The performance of the SMI over the last five years has been almost 22 per cent.*[i] While this may seem very low, especially compared to other major global indices, the appreciation of the Swiss franc against major currencies, or the weakening of major currencies against the Swiss franc, must also be taken into account. This represents an additional return for an investor in Swiss assets. A certain advantage of the SMI index is its relative stability, so investors are exposed to a lower risk of volatility, again compared to other global exchanges.


 

Swiss blue chips

Another option is to focus on individual stock titles traded on the Swiss stock exchange. Here too, however, it is worth choosing from the so-called blue chips, i.e. the top 20 stocks traded on the Swiss exchange.

 

These stocks include virtually all well-known and famous Swiss companies such as Nestlé, Novartis, ABB, Holcim and a number of Swiss financial houses - banks and insurance companies.

 

For example, on this page you will find a detailed overview of the performance of the individual Swiss blue chips. Since the beginning of this year, the Lonza Group (pharmaceutical, biotechnology and nutritional sector) has gained the most, by more than 30 percent.*[ii] The biggest year-on-year increase was recorded by Logitech, up almost 54 percent,*[iii] while the banking house UBS Group leads the way with a 71.19 percent*[iv] increase over the three-year period.

 

Among the industrial companies, ABB appears to be the most interesting, with its shares showing the third highest three-year performance of +50.19 percent.*[v] Year-to-date, ABB shares are up nearly 30 percent, having added nearly eight percent since the beginning of this year.

 

In conclusion, investing in Swiss assets is interesting in bad times but also in good times. However, it always depends on what goal you are pursuing with your investment. Above all, whether you want to avoid losing too much value in turbulent times, whether you are focusing on the long term or whether you are looking for short-term, quick appreciation. In any case, exchange rate risk must also be taken into account, which means, among other things, monitoring the monetary policy of the Swiss National Bank, but also the ECB and the CNB.

 

David Matulay

Analyst

InvestingFox

 

More about the company on InvestingFox.com

 

[*] Past performance is no guarantee of future results.

Snímek obrazovky 2024-03-06 v 11.48.18

[i]

Source: https://www.investing.com/equities/switzerland

 

Snímek obrazovky 2024-03-06 v 11.49.16

[ii]

Source: https://www.investing.com/equities/switzerland

Snímek obrazovky 2024-03-06 v 11.49.52

[iii]  Source: https://www.investing.com/equities/switzerland

Snímek obrazovky 2024-03-06 v 11.50.25

[iv]

Source: https://www.investing.com/equities/switzerland

Snímek obrazovky 2024-03-06 v 11.50.57

[v]  Source: https://www.investing.com/equities/switzerland

Read more

Strong Results, Weak Market Reaction – What’s Happening with Nvidia?

Strong Results, Weak Market Reaction – What’s Happening with Nvidia?

One of the most popular companies on Wall Street, Nvidia, released its earnings on Wednesday, February 26, 2025, confirming impressive growth in the AI chip segment. Despite this, its stock faced pressure due to expectations of a decline in gross margin, which created uncertainty among investors. However, the positive news is that Nvidia has secured enough manufacturing capacity for this year with its main supplier, TSMC. Yet, it faces the risk of new tariffs imposed by the US government.

Eli Lilly Lowers the Price of Its Weight Loss Drug: More Affordable Treatment or Strategic Business Move?

Eli Lilly Lowers the Price of Its Weight Loss Drug: More Affordable Treatment or Strategic Business Move?

Pharmaceutical giant Eli Lilly has made a significant shift in its pricing strategy for the popular weight-loss drug Zepbound. The company announced that selected doses would be available at a lower price to help patients without adequate health insurance while strengthening its market position. This move comes at a time when regulatory authorities have declared the end of the drug shortage, and Eli Lilly faces growing competition. Additionally, the company is investing heavily in developing an oral alternative, which could significantly reshape the market. 

Mercedes-Benz: New Strategies on the Road to Reviving the European Market

Mercedes-Benz: New Strategies on the Road to Reviving the European Market

Recent financial results from Mercedes-Benz reveal that the company faced a harsh wake-up call last year, as it struggled with the slowing shift to electric vehicles and weakening demand in China, once an inexhaustible source of profits for German automakers. Its challenges reflect the tough period during which European vehicle manufacturers are grappling with sharp declines in sales, especially in the electric vehicle sector. However, early sales data for this year suggests improvement, which could be the first sign of market recovery.

CVS Health closed 2024 with strong results and ambitious growth plans

CVS Health closed 2024 with strong results and ambitious growth plans

CVS Health, one of the largest healthcare companies in the U.S., surprised investors with positive results for the fourth quarter of 2024. Despite challenges, it managed to exceed expectations and demonstrated stable growth in key segments. The company also presented ambitious plans for 2025, which include cost reduction and strategic improvements in Medicare Advantage insurance.